Gansu Lanyao Pharmaceutical Co., Ltd.

1. Stimulate the pancreatic beta cells to secrete insulin, the prerequisite is that the pancreatic beta cells still have a certain ability to synthesize and secrete insulin; 2. By increasing the level of portal vein insulin or directly acting on the liver, inhibiting liver glycogenolysis and gluconeogenesis, the liver produces and outputs less glucose; 3. It may also increase the sensitivity of extra-pancreatic tissues to insulin and the utilization of sugar (probably mainly through post-receptor effects). Therefore, the overall effect is to lower fasting blood sugar and postprandial blood sugar.

This product is a cysteine derivative. After taking it, it combines with protein under the alkaline conditions of the duodenum to form a soluble substance that is quickly absorbed by the intestine, enhancing the function of the bone marrow hematopoietic system.

By inhibiting the early synthesis of bacterial cell walls, bacterial cell wall synthesis is inhibited, leading to their death

Interfere with bacterial folic acid metabolism, selectively inhibit the activity of bacterial dihydrofolate reductase, prevent dihydrofolate from being reduced to tetrahydrofolate, and prevent the synthesis of bacterial nucleic acids and proteins

It can cause blood vessels to contract, reduce capillary permeability, enhance platelet aggregation and adhesion, promote platelets to release coagulation active substances, shorten coagulation time, and achieve hemostatic effect.

It can cause blood vessels to contract, reduce capillary permeability, enhance platelet aggregation and adhesion, promote platelets to release coagulation active substances, shorten coagulation time, and achieve hemostatic effect.